Young Adult Infusion Space Experience Satisfaction Survey
Launched by UNC LINEBERGER COMPREHENSIVE CANCER CENTER · Jan 31, 2023
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how satisfied young adults, ages 18 to 39, are with their experience while receiving cancer treatment in two different infusion spaces at the North Carolina Basnight Cancer Hospital. The study aims to gather feedback from participants through surveys and interviews, focusing on factors like the environment they are treated in and their interactions with mental health staff.
To be eligible for this study, participants must be between 18 and 39 years old, currently receiving treatment for cancer, and able to speak English. They also need to provide written consent to participate. Unfortunately, individuals with certain mental health conditions or those who are currently incarcerated cannot take part in the trial. Participants will share their experiences, which will help improve the care and comfort of young adults undergoing cancer treatment in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Written informed consent obtained to participate in the study and HIPAA authorization for the release of personal health information.
- • 2. Subjects are willing and able to comply with study procedures based on the judgment of the investigator or protocol designee.
- • 3. Age 18-39 years old at enrollment.
- • 4. Receiving treatment for a cancer diagnosis in Adult Infusion Center or the Adolescent and Young Adult Infusion Center
- • 5. English speaking.
- Exclusion Criteria:
- • 1. Dementia, altered mental status, or any psychiatric condition as determined by the clinical or study team that would prohibit the understanding or rendering of informed consent.
- • 2. Current incarceration.
About Unc Lineberger Comprehensive Cancer Center
The UNC Lineberger Comprehensive Cancer Center is a leading research institution dedicated to advancing cancer treatment and prevention through innovative clinical trials and comprehensive patient care. As a National Cancer Institute-designated comprehensive cancer center, it integrates cutting-edge research, interdisciplinary collaboration, and patient-centered approaches to address diverse oncology challenges. With a commitment to translating scientific discoveries into effective therapies, UNC Lineberger strives to improve outcomes for patients while fostering a robust environment for education and training in cancer research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chapel Hill, North Carolina, United States
Patients applied
Trial Officials
Jacob Stein
Principal Investigator
UNC Lineberger Comprehensive Cancer Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials